Mao Fan, Jiang Yingying, Liu Jing, Zhang Yan, Jiang Yong, Wang Linhong, Zhao Dong, Huo Yong, Ge Junbo, Zhou Maigeng
National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Beijing Institute of Heart, Lung & Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
China CDC Wkly. 2022 Apr 1;4(13):265-270. doi: 10.46234/ccdcw2022.067.
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: The prevalence of cardiovascular disease (CVD) in China is high, while effective prevention and proper management is lacking. No available indicators were found before 2016 that could comprehensively evaluate different aspects of CVD prevention and treatment.
WHAT IS ADDED BY THIS REPORT?: Constructed by combining data from multiple dimensions, China cardiovascular health index (CHI) has provided a practical indicator for each provincial-level administrative division (PLAD) to comprehensively understand its overall level and rankings of the specific dimensions of cardiovascular health.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: The CHI will be beneficial for each PLAD to identify weak aspects in CVD control and prevention and redistribute resources to the most needed areas.
关于该主题已知的信息有哪些？：中国心血管疾病（CVD）的患病率很高，但缺乏有效的预防和适当的管理。2016年之前未发现可全面评估心血管疾病预防和治疗不同方面的可用指标。
本报告补充了哪些内容？：通过整合多维度数据构建的中国心血管健康指数（CHI）为每个省级行政区（PLAD）提供了一个实用指标，以全面了解其心血管健康特定维度的总体水平和排名。
对公共卫生实践有哪些启示？：CHI将有助于每个省级行政区识别心血管疾病控制和预防中的薄弱环节，并将资源重新分配到最需要的领域。
